Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US11241400 | NEXUS | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same |
May, 2040
(16 years from now) | |
US11464752 | NEXUS | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same |
May, 2040
(16 years from now) | |
US11090278 | NEXUS | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same |
May, 2040
(16 years from now) | |
US11571398 | NEXUS | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same |
May, 2040
(16 years from now) | |
US11478436 | NEXUS | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same |
May, 2040
(16 years from now) |
Market Authorisation Date: 28 February, 2023
Treatment: Use of ephedrine sulfate for treating hypotension
Dosage: SOLUTION;INTRAVENOUS
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10869845 | OPERAND PHARMS | Ephedrine compositions and methods |
Jan, 2040
(15 years from now) |
Market Authorisation Date: 22 April, 2022
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS